By proceeding, you agree to our Terms of Use and Privacy Policy.
Enhance Your Prediction of PKPD, Accurate Dosing Regime & Immuno-Modulation of LNP for Long-Term Patient Safety & Potency Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic
Enhance Your Prediction of PKPD, Accurate Dosing Regime & Immuno-Modulation of LNP for Long-Term Patient Safety & Potency.
The 2022 Expert Speaker Faculty includes those from Oncorus, Vertex Pharmaceuticals, Bristol Myers Squibb, Sanofi Pasteur, Eli Lilly & Company.
Explore Immunomodulation strategies to increase the therapeutic window, learn about Translatable preclinical models to revolutionize clinical relevancy.
Leverage 6+ hours of networking! Join AstraZeneca, Bristol Myers Squibb & more on robust immunotoxicity protocols, propelling your novel pipeline growth.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Integrated Nanotherapeutics Inc.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.